BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cancer Epigenetics Society - ECPv5.3.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cancer Epigenetics Society
X-ORIGINAL-URL:https://ces.b2sg.org
X-WR-CALDESC:Events for Cancer Epigenetics Society
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20170326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20171029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171125
DTEND;VALUE=DATE:20171227
DTSTAMP:20260729T092701
CREATED:20171125T215520Z
LAST-MODIFIED:20171125T215549Z
UID:19420-1511568000-1514332799@ces.b2sg.org
SUMMARY:Postdoctoral Research Fellow
DESCRIPTION:The Postdoc Rsh Fellow\, Epigenetic will function under the supervision of a Senior Scientist and Director of the Division of Genetics and Epigenetics. The laboratory has a long standing research program on epigenetics and DNA methylation in normal human development and in common diseases\, including cancer\, Down syndrome\, Alzheimer’s disease and other neurodegenerative disorders\, and autoimmune diseases. Areas of current emphasis include mechanistic studies on genetic-epigenetic interactions that occur in cis and in trans\, using both human samples and mouse models\, and the use of epigenomic mapping as a ‘post-GWAS’ method to identify genes and DNA variants that underlie disease susceptibility. We are also studying epigenetically-acting anti-cancer drugs\, seeking to understand how these agents affect tumor cells and stromal and immune system cells in the tumor microenvironment. Opportunities for post-doctoral training in our group therefore encompass the areas of genome and epigenome analysis using whole genome and targeted approaches in human samples and informative mouse models\, the development of useful bioinformatic methods\, and pre-clinical studies of epigenetically-acting anti-cancer therapies and their effects on the tumor microenvironment in tumor-prone mouse models. \n1. May design and perform whole genome and epigenome analyses in human samples and appropriate mouse models\, for understanding mechanisms of disease susceptibility. \n2. May develop and apply useful bioinformatic approaches to genomic and epigenomic data for testing mechanistic hypotheses. \n3. Present results in internal and external research forums. \n4. Participate in grant and manuscript writing\, as appropriate. \n5. May design and conduct animal studies using murine models of cancer and Down syndrome. \n6. May design and conduct immunological profiling studies in mouse models of Down syndrome and cancer. \nWorking Conditions: \nEducation\, Knowledge\, Skills and Abilities Required: \n1. Hold a Ph.D. or M.D. Degree from an accredited medical school or graduate level institution. \n2. Minimum publication or in preparation of two articles as first author in high quality peer-reviewed scientific journals. 
URL:https://ces.b2sg.org/event/hackensack-nov2517/
LOCATION:Hackensack University Medical Center\, 30 Prospect Ave\, Hackensack\, NJ\, 07601\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/11/Hackensack-University-Medical-Center.jpg
END:VEVENT
END:VCALENDAR